{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T03:06:34Z","timestamp":1789873594415,"version":"4.0.1"},"reference-count":62,"publisher":"Informa UK Limited","issue":"6","funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["5 NU17CE924899, 6 NU17CE010208-01-01., 6 NU17CE010208-01-01"],"award-info":[{"award-number":["5 NU17CE924899, 6 NU17CE010208-01-01., 6 NU17CE010208-01-01"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Substance Use &amp; Misuse"],"published-print":{"date-parts":[[2025,5,12]]},"DOI":"10.1080\/10826084.2025.2454653","type":"journal-article","created":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T11:47:26Z","timestamp":1738151246000},"page":"818-827","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["Assessing Prevalence of Nonmedically Used Prescription Drug Involvement in Overdose Deaths Through Linkage of State Unintentional Drug Overdose Reporting System and Controlled Substances Monitoring Program Data"],"prefix":"10.1080","volume":"60","author":[{"given":"Jessica","family":"Korona-Bailey","sequence":"first","affiliation":[{"name":"Tennessee Department of Health, Office of Informatics and Analytics","place":["Nashville, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenna","family":"Moses","sequence":"additional","affiliation":[{"name":"CDC Foundation","place":["Atlanta, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sutapa","family":"Mukhopadhyay","sequence":"additional","affiliation":[{"name":"Tennessee Department of Health, Office of Informatics and Analytics","place":["Nashville, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,1,29]]},"reference":[{"key":"e_1_3_7_2_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2019.00228"},{"key":"e_1_3_7_3_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2011.1827"},{"key":"e_1_3_7_4_1","doi-asserted-by":"publisher","DOI":"10.1080\/15402002.2017.1403325"},{"key":"e_1_3_7_5_1","unstructured":"America\u2019s Health Rankings. (2023). Nonmedical drug use past year in the United States. Denver Health and Hospital Authority RADARS\u00ae System Survey of Non-Medical Use of Prescription Drugs Program. Explore Non-Medical Drug Use - Past Year in the United States | AHR (americashealthrankings.org)"},{"key":"e_1_3_7_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2009.10.002"},{"key":"e_1_3_7_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2017.10.023"},{"key":"e_1_3_7_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.japh.2021.01.025"},{"key":"e_1_3_7_9_1","unstructured":"Centers for Disease Control and Prevention. (2024 May 13). Injuries and violence are leading causes of death. https:\/\/www.cdc.gov\/injury\/wisqars\/animated-leading-causes.html"},{"key":"e_1_3_7_10_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2015-2480"},{"key":"e_1_3_7_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2020.106290"},{"key":"e_1_3_7_12_1","doi-asserted-by":"publisher","DOI":"10.2190\/DE.41.3.e"},{"key":"e_1_3_7_13_1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.200191"},{"key":"e_1_3_7_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2016.04.002"},{"key":"e_1_3_7_15_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.17383"},{"key":"e_1_3_7_16_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13011-022-00480-4"},{"key":"e_1_3_7_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2020.108013"},{"key":"e_1_3_7_18_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.pn.2023.11.11.29"},{"key":"e_1_3_7_19_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2015.302689"},{"key":"e_1_3_7_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2019.103208"},{"key":"e_1_3_7_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2008.08.010"},{"key":"e_1_3_7_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jen.2006.01.010"},{"key":"e_1_3_7_23_1","doi-asserted-by":"publisher","DOI":"10.3310\/eme07070"},{"key":"e_1_3_7_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2018.02.010"},{"key":"e_1_3_7_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.abrep.2020.100289"},{"key":"e_1_3_7_26_1","first-page":"1","article-title":"2013 NCHS urban-rural classification scheme for counties","volume":"166","author":"Ingram D. D.","year":"2014","unstructured":"Ingram, D. D., & Franco, S. J. (2014). 2013 NCHS urban-rural classification scheme for counties. Vital and health statistics. Series 2, data evaluation and methods research (Vol. 166, pp. 1\u201373). https:\/\/www.cdc.gov\/nchs\/data\/series\/sr_02\/sr02_166.pdf","journal-title":"Vital and health statistics. Series 2, data evaluation and methods research"},{"key":"e_1_3_7_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sapharm.2023.10.014"},{"key":"e_1_3_7_28_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7129e2"},{"key":"e_1_3_7_29_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-021-11551-9"},{"key":"e_1_3_7_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhealeco.2020.102408"},{"key":"e_1_3_7_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annepidem.2021.03.004"},{"key":"e_1_3_7_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cppeds.2022.101265"},{"key":"e_1_3_7_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11469-023-01084-0"},{"key":"e_1_3_7_34_1","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.2012.3972"},{"key":"e_1_3_7_35_1","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000150"},{"key":"e_1_3_7_36_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.201800321"},{"key":"e_1_3_7_37_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.22650"},{"key":"e_1_3_7_38_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.202000183"},{"key":"e_1_3_7_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.108706"},{"key":"e_1_3_7_40_1","doi-asserted-by":"publisher","DOI":"10.1097\/jcp.0b013e31822bb378"},{"key":"e_1_3_7_41_1","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2023.2287194"},{"issue":"5","key":"e_1_3_7_42_1","first-page":"297","article-title":"State prescription drug monitoring programs and fatal drug overdoses","volume":"23","author":"Nam Y. H.","year":"2017","unstructured":"Nam, Y. H., Shea, D. G., Shi, Y., & Moran, J. R. (2017). State prescription drug monitoring programs and fatal drug overdoses. The American Journal of Managed Care, 23(5), 297\u2013303. https:\/\/www.ajmc.com\/view\/state-prescription-drug-monitoring-programs-and-fatal-drug-overdoses","journal-title":"The American Journal of Managed Care"},{"key":"e_1_3_7_43_1","unstructured":"National Institutes of Health. (2020). Misuse of prescription drugs research report: Overview. National Institute on Drug Abuse. https:\/\/nida.nih.gov\/publications\/research-reports\/misuse-prescription-drugs\/overview"},{"key":"e_1_3_7_44_1","volume-title":"Screening for unhealthy drug use in primary care in adolescents and adults, including pregnant persons: Updated systematic review for the US","author":"Patnode C. D.","year":"2020","unstructured":"Patnode, C. D., Perdue, L. A., Rushkin, M., & O\u2019Conner, E.A. (2020). Screening for unhealthy drug use in primary care in adolescents and adults, including pregnant persons: Updated systematic review for the US. Agency for Healthcare Research and Quality (US). (Evidence Synthesis. No. 186.) https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK558174\/"},{"key":"e_1_3_7_45_1","doi-asserted-by":"publisher","DOI":"10.1177\/1087054708320399"},{"key":"e_1_3_7_46_1","unstructured":"Roberts A. & Saint S. (2021 June 22\u201323). Enhancing SUDORS in Tennessee: Using web forms and automation to improve data quality reduce errors and save time [Conference presentation]. Overdose Data to Action Recipient Meeting Virtual."},{"key":"e_1_3_7_47_1","doi-asserted-by":"publisher","DOI":"10.1177\/10901981221116778"},{"key":"e_1_3_7_48_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.15m10386"},{"key":"e_1_3_7_49_1","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare11030437"},{"key":"e_1_3_7_50_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e31822bb378"},{"key":"e_1_3_7_51_1","doi-asserted-by":"publisher","DOI":"10.1093\/pm\/pnz304"},{"key":"e_1_3_7_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2019.02.010"},{"key":"e_1_3_7_53_1","unstructured":"Substance Abuse and Mental Health Services Administration. (2023a November). Key substance use and mental health indicators in the United States: Results from the 2022 national survey on drug use and health. https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/reports\/rpt42731\/2022-nsduh-nnr.pdf"},{"key":"e_1_3_7_54_1","unstructured":"Substance Abuse and Mental Health Services Administration. (2023b November). Results from the 2022 national survey on drug use and health: Detailed tables. https:\/\/www.samhsa.gov\/data\/report\/2022-nsduh-detailed-tables"},{"key":"e_1_3_7_55_1","unstructured":"Tennessee Department of Health. (2024). Controlled substances monitoring database program. https:\/\/www.tn.gov\/health\/health-program-areas\/health-professional-boards\/csmd-board.html"},{"key":"e_1_3_7_56_1","unstructured":"Tennessee Department of Mental Health & Substance Abuse Services. (2015). Prescription drug take-back boxes. https:\/\/www.tn.gov\/content\/dam\/tn\/mentalhealth\/documents\/TDMHSAS_TakeBackBoxes_Oct21.pdf"},{"key":"e_1_3_7_57_1","doi-asserted-by":"publisher","DOI":"10.1177\/0897190018783887"},{"key":"e_1_3_7_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2009.02.006"},{"key":"e_1_3_7_59_1","unstructured":"United Nations Office on Drugs and Crime. (2011 September). The non-medical use of prescription drugs. Policy direction issues. https:\/\/www.unodc.org\/documents\/drug-prevention-and-treatment\/nonmedical-use-prescription-drugs.pdf"},{"key":"e_1_3_7_60_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.6774"},{"key":"e_1_3_7_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2019.02.033"},{"key":"e_1_3_7_62_1","doi-asserted-by":"publisher","DOI":"10.1177\/0033354919878429"},{"key":"e_1_3_7_63_1","doi-asserted-by":"publisher","DOI":"10.18773\/austprescr.2015.058"}],"container-title":["Substance Use &amp; Misuse"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10826084.2025.2454653","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T06:56:25Z","timestamp":1743231385000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10826084.2025.2454653"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,29]]},"references-count":62,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,5,12]]}},"alternative-id":["10.1080\/10826084.2025.2454653"],"URL":"https:\/\/doi.org\/10.1080\/10826084.2025.2454653","relation":{},"ISSN":["1082-6084","1532-2491"],"issn-type":[{"value":"1082-6084","type":"print"},{"value":"1532-2491","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,29]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=isum20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=isum20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-01-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}